entity

Tau Propagation Blockade

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Tau Propagation Blockade: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

0Connections
3Hypotheses
0Analyses
0Outgoing
0Incoming
10Experiments
0Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Noradrenergic-Tau Propagation Blockade 0.711 neurodegeneration Sleep disruption as cause and consequenc
TREM2-Mediated Microglial Dysfunction Impairs Synaptic Tau P 0.380 neuroscience TREM2 in Alzheimer's Disease: Mechanisms
Tau Propagation Blockade via Synaptic Ephrin-B2/ephrin-B Sig 0.267 connectomics Human connectome alterations in Alzheime

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (10)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
s:** - Compare tau strain spreading in EXT1/EXT2 conditional knockout falsification Neurodegeneration 0.400 0.50 mouse proposed $260,000
4R-Tau Targeting Therapies for PSP and CBS clinical Alzheimer's Disease 0.400 0.50 human proposed $6,550,000
Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation and Neuro exploratory Parkinson's Disease 0.400 0.50 human proposed $2,070,000
Anti-Tau Immunotherapy Dosing Optimization clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Blood Biomarker vs Tau PET for Treatment Monitoring clinical ALS 0.400 0.50 human proposed $5,460,000
Combination Therapy Sequencing in Parkinson's Disease validation Parkinson's Disease 0.400 0.50 human proposed $2,280,000
Alpha-Synuclein Staging and Spreading in DLB — Spatial Propagation Map validation Parkinson's Disease 0.400 0.50 cell_line proposed $160,000
Tau Co-Pathology in DLB Clinical Heterogeneity clinical Neurodegeneration 0.400 0.50 human proposed $5,460,000
Levodopa Response Determinants in PSP — Biomarker-Guided Prediction St clinical Neurodegeneration 0.400 0.50 human proposed $5,460,000
Experiment: Multi-Ethnic PD GWAS clinical Parkinson's Disease 0.400 0.50 human proposed $7,500,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 po [PMID:31227597] Snyder AG, Hubbard NW, Messmer MN, Kofma Sci Immunol 2019 1
Effect of etching with potassium hydrogen difluoride and ammonium hydrogen diflu [PMID:31068549] Akazawa N, Koizumi H, Nogawa H, Kodaira Dent Mater J 2019 1
Synapse formation in the brain can be enhanced by co-administering three specifi [PMID:29031899] Wurtman RJ Eur J Pharmacol 2017 1
Engineered AAVs for efficient noninvasive gene delivery to the central and perip [PMID:28671695] Chan KY, Jang MJ, Yoo BB, Greenbaum A, R Nat Neurosci 2017 1
The Pediatric Imaging, Neurocognition, and Genetics (PING) Data Repository. [PMID:25937488] Jernigan TL, Brown TT, Hagler DJ Jr, Aks Neuroimage 2016 1
Regulation of Lipid Biology-Associated Gene Expression in Granulosa Cells in Hyp [PMID:41605187] ["Berkel C"] Lipids 2026 0
Meta-GWAS of Pig Semen Quality Traits Reveals Conserved Genes Regulating Mammali [PMID:41504393] ["Lin Q", "Cai X", "Zhong Z", "Li T", "C Advanced science (Weinheim, Ba 2026 0
Necl1 deficiency induces noradrenergic dysfunction and depressive-like states in [PMID:41308882] ["Song J", "Wang L", "Suo J", "Ran K", " Journal of affective disorders 2026 0
The contribution of phenolic endocrine-disrupting chemicals to breast cancer ris [PMID:41673191] ["Dou Y", "Li X", "Li M", "Shang J", "Xu Scientific reports 2026 0
Transcriptomics reveals new therapeutic targets for ovarian cancer. [PMID:41577183] ["Feng Y", "Liu G"] SLAS technology 2026 0
Noradrenergic inhibition of definitive POMC neurons through direct and indirect [PMID:41877438] Lavoie O, Turmel A, Khouma A, Minbashi M Journal of neuroendocrinology 2026 0
The Neuroimmunome of Hepatitis Patients Associates With Disease Severity. [PMID:41347690] ["N\u00f3bile A", "Adri A", "Usuda J", " Journal of medical virology 2025 0
Neuro-Mesenchymal Interaction Mediated by a β2-Adrenergic Nerve Growth Factor Fe [PMID:39137067] ["Kobayashi H", "Iida T", "Ochiai Y", "M Cancer discovery 2025 0
Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and [PMID:41058112] ["Santos A", "de Souza T", "Aguiar K", " American journal of medical ge 2025 0
Probiotic Bactolac alleviates depression-like behaviors by modulating BDNF, NLRP [PMID:40281288] ["I\u015f\u0131k M", "K\u00f6se F", "Bud Pflugers Archiv : European jou 2025 0
Promising Antidepressant Potential: The Role of Lactobacillus rhamnosus GG in Me [PMID:39962033] ["I\u015f\u0131k M", "K\u00f6se F", "\u0 Probiotics and antimicrobial p 2025 0
Unveiling the molecular mechanisms of human platelet lysate in enhancing endomet [PMID:40663777] ["Nguyen T", "Kwok Y", "Zhang C", "Russe Human reproduction (Oxford, En 2025 0
Sympathetic nerve-enteroendocrine L cell communication modulates GLP-1 release, [PMID:38242116] ["Ren W", "Chen J", "Wang W", "Li Q", "Y Neuron 2024 0
Enterococcus-derived tyramine hijacks α [PMID:38788722] ["Li C", "Zhang P", "Xie Y", "Wang S", " Cell host & microbe 2024 0
Tumour immune rejection triggered by activation of α2-adrenergic receptors. [PMID:37286594] Zhu J, Naulaerts S, Boudhan L, Martin M, Nature 2023 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Tau Propagation Blockade in their description or question text

No additional research found